Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

11 Malaysia Hyperglycemics Reports

APAC Insulin Market

Country Covered: Malaysia

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee

Asia Pacific SGLT2 Inhibitors Market

Country Covered: Malaysia

Study Period: 2018 - 2029

Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb

APAC Biguanide Industry

Country Covered: Malaysia

Study Period: 2019 - 2029

Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis

APAC Meglitinide Industry

Country Covered: Malaysia

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon

Insulin Market

Country Covered: Malaysia

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

Biguanides Market

Country Covered: Malaysia

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

Meglitinides Market

Country Covered: Malaysia

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

Sulfonylureas Industry

Country Covered: Malaysia

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Country Covered: Malaysia

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Malaysia

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Glargine Insulin Market

Country Covered: Malaysia

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar